Study of Continuous OSI-906 Dosing

Clinical trial NCT00514007 · COMPLETED

Trial details

NCT number: NCT00514007
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2007-06-18
Primary completion: 2012-03-19
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.